BioSpace News Archive

Press Releases

Nevro Reports Third-Quarter 2024 Financial Results

November 12, 2024
·
18 min read
Press Releases

Nipocalimab is the first and only investigational therapy granted U.S. FDA Breakthrough Therapy Designation for the treatment of adults living with moderate-to-severe Sjögren’s disease

November 12, 2024
·
13 min read
Press Releases

Quince Therapeutics Presents Safety Data from Prior Phase 3 ATTeST Clinical Trial at 53rd Child Neurology Society Annual Meeting

November 12, 2024
·
7 min read
Press Releases

Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2024

November 12, 2024
·
2 min read
Press Releases

Arcturus Therapeutics Receives Clearance from FDA to Begin H5N1 Pandemic Flu Vaccine Clinical Trial

November 12, 2024
·
4 min read
Press Releases

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - November 11, 2024

November 12, 2024
·
1 min read
Press Releases

Neurogene Reports Positive Interim Efficacy Data from First Four Low-Dose Pediatric Participants in NGN-401 Gene Therapy Clinical Trial for Rett Syndrome

November 12, 2024
·
11 min read
Press Releases

Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Itovebi™ (inavolisib)

November 12, 2024
·
4 min read
Press Releases

Zevra Therapeutics to Present Data Demonstrating Relevance of Swallow Domain in Niemann-Pick Disease Type C Clinical Severity Scale at 53rd Child Neurology Society Annual Meeting

November 12, 2024
·
6 min read
Press Releases

DBV Technologies Announces Plan to Implement ADS Ratio Change

November 12, 2024
·
5 min read